The Genomic Medicine Institute is committed to performing translational and clinical human genetics and genomics investigation and fostering innovation toward realizing the benefits of personalized genomic-based healthcare.
Cleveland Clinic researchers create AI tool for Alzheimer’s target and drug discovery
11/29/2022
The open-source artificial intelligence (AI) technology uses human genetic data to identify candidate drugs.
Read More
Cleveland Clinic study identifies blood pressure drug as potential treatment for Black patients with Alzheimer’s disease
11/04/2022
Analyzing data from more than 5 million patients revealed telmisartan is associated with lower Alzheimer’s disease incidence in Black patients, providing clues for potential treatment and prevention.
Read More
Metformin identified as a potential atrial fibrillation treatment in collaborative research
10/11/2022
How drugs and atrial fibrillation affect functions and genes in the body is the subject of a recent study into metformin and other candidate drugs.
Read More